Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
about
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational ProspectiveCardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicabilityGDF-15, iron, and inflammation in early chronic kidney disease among elderly patients.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Not so benign haematology: anaemia of the elderlyGDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study.Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes.Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo.Biomarkers of cardiovascular stress and incident chronic kidney disease.Use of Proteomics To Investigate Kidney Function Decline over 5 Years.Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15.Smoking as a risk factor for diabetic nephropathy: a meta-analysis.Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.Study of the association between growth differentiation factor 15 gene polymorphism and coronary artery disease in a Chinese population.Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors.Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause.Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes.Circulating proteins as predictors of incident heart failure in the elderly.Growth differentiation factor 15 as a predictor of adverse renal outcomes in patients with immunoglobulin A nephropathy.Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity.Biomarkers of diabetic nephropathy: A 2017 update.Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria.Growth Differentiation Factor-15 and Risk of CKD Progression.Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes.Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium.Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study.Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study.The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome
P2860
Q26798142-1ABD7CF4-9857-4BD7-A3E6-9E9AE2026BD4Q28081407-CC5DC785-E55F-4A10-9E6F-DBFE026EED8AQ33362887-05D3E11F-A719-4AC2-9C2B-5F7AB231A55CQ34219439-08DA45B9-3E4C-4D0B-AA64-C83DE01A4AA7Q35631773-B965DDBC-0C36-4285-98C0-90AFE6D28A12Q35920919-8B109CC0-BFFD-4BA5-9C93-324F2A37C9DEQ35924547-EF05F65E-FF5A-4BED-A132-99EFADE473F7Q36334558-9683DE7D-CBFB-442B-B27F-CB415F4BC1D6Q36893044-EFAE3B33-5E52-44AC-A8A3-EBA50C5E5567Q37678391-D953C72F-7F0F-43B3-A37B-7550FFCC1C54Q38636118-C72EB834-4FCC-4679-9EBA-5CF7003B7900Q38653870-C531FA70-F821-47B4-90F3-842EB29FFFA9Q38718018-7A3914BC-B3ED-44CF-90AD-4F17EE576BC1Q38908409-4C5A8405-B199-4472-9479-36268385738DQ39783969-D0BC1668-1081-47B8-82B4-B636A07F6F55Q41939161-F49EAF76-E835-4A0A-9A53-8972B4BFDE69Q44777390-D800CFAF-5725-4236-981A-24D4D012B249Q45177029-96F4A628-DE9E-41BB-8839-BD710D336CE5Q47670392-3E9FD24F-77D5-406B-B94C-BEF601617FAEQ48132987-CA39587C-8D3C-48BC-BD39-4DAE230CC8EDQ48574810-8DCD0E2E-CD78-4FDE-9148-218A9E3FCC33Q49686004-2B9BDD3A-DB73-4073-8BFF-1D1328526EE5Q50129204-4F6F8FCA-1C7B-4F98-AE5B-CD435704A3EFQ51153601-4A017070-A533-4559-A352-8384DD0C9895Q52563152-47C578AB-135A-4B4C-A4FE-10300CDA2E94Q52632771-3170A511-0C10-471A-B265-F379F0E98D35Q54979361-4D5FD87B-1FCA-4D5F-B4DE-7A393DAAB07AQ55073803-C738EE90-6835-4D82-B5DB-EAB53F8C09D5Q58788261-93322BE5-13E1-4552-8968-495114E97AA5
P2860
Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Plasma growth differentiation ...... tic patients with nephropathy.
@ast
Plasma growth differentiation ...... tic patients with nephropathy.
@en
type
label
Plasma growth differentiation ...... tic patients with nephropathy.
@ast
Plasma growth differentiation ...... tic patients with nephropathy.
@en
prefLabel
Plasma growth differentiation ...... tic patients with nephropathy.
@ast
Plasma growth differentiation ...... tic patients with nephropathy.
@en
P2860
P50
P356
P1433
P1476
Plasma growth differentiation ...... tic patients with nephropathy.
@en
P2093
Hans-Henrik Parving
Maria Lajer
P2860
P304
P356
10.2337/DC09-2174
P407
P577
2010-03-31T00:00:00Z